Trial Profile
A multicentre study evaluating everolimus eluting stent with absorbable polymer, Synergy™ in patients with lesions for early healing, assessed with optical coherence tomography.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Apr 2017
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease; Solid tumours
- Focus Therapeutic Use
- 06 Apr 2017 New trial record